We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 11-20 of 866

Another Sequenom patent appeal heads to the Federal Circuit
  • Foley & Lardner LLP
  • USA
  • June 2 2015

While Sequenom’s appeal of the district court’s summary judgment of invalidity of U.S. Patent 6,258,540 under 35 USC 101 has been pending at the


Apple v. Samsung: design patents reap profits
  • Foley & Lardner LLP
  • USA
  • May 29 2015

Design patents are an often-overlooked form of intellectual property, lying somewhere at the crossroads of trademark law, utility patent law, and


Dependent claims give rise to improper broadening reissue
  • Foley & Lardner LLP
  • USA
  • May 27 2015

In ArcelorMittal France v. AK Steel Corp., the Federal Circuit found that the addition of a dependent claim to a reissue application improperly


Supreme Court holds good faith belief of invalidity not a defense to induced infringement claim
  • Foley & Lardner LLP
  • USA
  • May 26 2015

The U.S. Supreme Court held yesterday in Commil USA, LLC v. Cisco Sys., Inc. (No. 13-896) that a defendant's belief regarding patent invalidity is


Patent safe harbor applies to supplemental new drug applications
  • Foley & Lardner LLP
  • USA
  • May 21 2015

On May 13, 2015, the Federal Circuit confirmed in Classen Immunotherapies, Inc. v. Elan Pharmaceuticals, Inc. that the safe harbor provisions of 35 U


Federal Circuit finds no direct infringement of Akamai patents
  • Foley & Lardner LLP
  • USA
  • May 19 2015

The Federal Circuit issued its remand decision in Akamai Technologies, Inc. v. Limelight Networks, Inc., this time affirming the district court


The importance of contracts for joint infringement in patent cases
  • Foley & Lardner LLP
  • USA
  • May 19 2015

It has been about a year since the Supreme Court rendered its decision in Limelight v. Akamai regarding induced infringement for methods performed by


First look at false marking under the AIA
  • Foley & Lardner LLP
  • USA
  • May 14 2015

In Sukumar v. Nautilus, Inc., the Federal Circuit took its first look at the standing requirements to bring a false marking case under the American


California Supreme Court scrutinizes reverse payment ANDA settlements
  • Foley & Lardner LLP
  • USA
  • May 12 2015

In In Re Cipro Cases I & II, the California Supreme Court laid out a four-part rule of reason analysis for evaluating ANDA settlements that involve a


Federal Circuit keeps Sandoz biosimilar off the market for now
  • Foley & Lardner LLP
  • USA
  • May 6 2015

The Federal Circuit is set to hear oral arguments in Amgen v. Sandoz on June 3, but in the meantime has granted Amgen's motion for a preliminary